Remdesivir effective against COVID-19, researchers conclude
By
Alicia Lasek
Oct 13, 2020
Intravenous remdesivir shortens recovery time and reduces mortality in hospitalized patients when compared to placebo, according to final trial data from NIAID. No other antiviral has yet been confirmed...
BREAKING: CMS increases oversight of nursing home survey process and expands nursing home visitation...
By
Kimberly Marselas
Danielle Brown
Nov 12, 2021
Nursing homes should allow visitation for residents “at all times,” while state surveyors received steps on how to address a backlog of complaint and recertification surveys under two separate memos...
An antibody cocktail that halts disease progression in sick COVD-19 patients has been shown to prevent the disease altogether in healthy people who live in close contact with an infected person, the drugmaker...
More clinical benefits of molnupiravir ID’d in COVID-19
Jun 07, 2022
New benefits for certain COVID-19 patients, including reduced need for respiratory intervention, have been found for Merck’s COVID-19 pill molnupiravir.
Unforeseen consequences pile up in race to find COVID-19 treatments
By
Alicia Lasek
Mar 25, 2020
The national attention gained by an experimental drug and two existing medications has led to unintended trouble for patients.
New study links sarcopenic obesity to dementia; experts call for preventive action
By
Alicia Lasek (f3)
May 26, 2022
Obesity with decreased muscle mass and function is prevalent in older adults and is tied to a high risk of dementia, researchers say.
At-home COVID-19 tests get a $70M boost as feds push to increase access
By
Alicia Lasek
Oct 27, 2021
The Biden Administration is streamlining the process to bring new tests to market among other moves designed to increase testing supplies and access.
CDC says COVID-19 vaccine boosters not yet necessary, while Pfizer seeks approval for third dose
By
Alicia Lasek
Jul 12, 2021
Fully vaccinated Americans do not need a COVID-19 booster shot at this time, according to federal health officials. But Pfizer has asked to offer a third dose of its current vaccine and is developing an...
High blood pressure plus COVID doubles risk of hospital stay: study
By
Alicia Lasek (f3)
Jul 25, 2022
Even after three COVID-19 vaccine doses, high blood pressure more than doubles the risk for hospitalization with an omicron variant infection, researchers report.
First biosimilar approved by FDA to treat common eye degeneration in elders
By
Alicia Lasek
Sep 21, 2021
The Food and Drug Administration has approved a less expensive copy of the blockbuster drug Lucentis for treating age-related (wet) macular degeneration and several other eye conditions.